Albuminuria: Prevalence, associated risk factors and relationship with cardiovascular disease

Journal of Diabetes Investigation

Volumn 5, Issue 4, 2014, Pages 464-471

  Chen, Fang ^a   Yang, Wenying ^b   Weng, Jianping ^c   Jia, Weiping ^d   Ji, Linong ^e   Xiao, Jianzhong ^b   Shan, Zhongyan ^f   Liu, Jie ^g   Tian, Haoming ^h   Ji, Qiuhe ⁱ   Zhu, Dalong ^j   Ge, Jiapu ^k   Lin, Lixiang ^l   Chen, Li ^m   Guo, Xiaohui ⁿ   Zhao, Zhigang ^o   Li, Qiang ^p   Zhou, Zhiguang ^q   Shan, Guangliang ^r   Lu, Juming ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^e PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^f CHINA MEDICAL UNIVERSITY   (China)

^g SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^h SICHUAN UNIVERSITY   (China)

ⁱ FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^j THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^k Xinjiang Uygur Autonomous Region's Hospital   (China)

^l FUJIAN PROVINCIAL HOSPITAL   (China)

^m SHANDONG UNIVERSITY   (China)

ⁿ PEKING UNIVERSITY FIRST HOSPITAL   (China)

^o HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^p THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^q CENTRAL SOUTH UNIVERSITY   (China)

^r INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

more..

Author keywords

Albuminuria; Cardiovascular disease; Diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; AGING; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX SPECIFIC ALBUMIN TO CREATININE RATIO CUT POINT; SINGLE ALBUMIN TO CREATININE RATIO CUT POINT; SYSTOLIC BLOOD PRESSURE; URINALYSIS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84904673889     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12172     Document Type: Article

References (38)

1. Meguid ENA, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331 -340.
2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med Overseas Ed 2004; 351: 1296 -1305.
3. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003; 14(7 Suppl 2): S131 -S138.
4. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1 -12.
5. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275 -2284.
6. Nugent RA, Fathima SF, Feigl AB, et al. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 2011; 118: c269 -c277.
7. Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66: 1310 -1314.
8. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815 -822.
9. Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; 380: 1662 -1673.
10. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073 -2081.
11. Mahmoodi BK, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012; 380: 1649 -1661.
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1 -S266.
13. Warram JH, Gearin G, Laffel L, et al. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996; 7: 930 -937.
14. Rachmani R, Levi Z, Lidar M, et al. Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year follow-up study of 599 patients. Diabetes Res Clin Pract 2000; 49: 187 -194.
15. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421 -426.
16. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777 -1782.
17. Xu J, Knowler WC, Devereux RB, et al. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis 2007; 49: 208 -216.
18. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med Overseas Ed 2010; 362: 1090 -1101.
19. Xu R, Zhang L, Zhang P, et al. Gender-specific reference value of urine albumin-creatinine ratio in healthy Chinese adults: results of the Beijing CKD survey. Clin Chim Acta 2008; 398: 125 -129.
20. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007; 35: 390 -419 (Chinese).
21. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome -a new worldwide definition. Lancet 2005; 366: 1059 -1062.
22. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151 -183.
23. Qu HQ, Li Q, Rentfro AR, et al. The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS ONE 2011; 6: e21041.
24. Esteghamati A, Ashraf H, Khalilzadeh O, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond) 2010; 7: 26.
25. Saydah SH, Pavkov ME, Zhang C, et al. Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009-2010. Clin Chem 2013; 59: 675 -683.
26. Kenealy T, Elley CR, Collins JF, et al. Increased prevalence of albuminuria among non-European peoples with type 2 diabetes. Nephrol Dial Transplant 2012; 27: 1840 -1846.
27. Miller WG, Bruns DE, Hortin GL, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009; 55: 24 -38.
28. Klasen IS, Reichert LJ, de Kat Angelino CM, et al. Quantitative determination of low and high molecular weight proteins in human urine: influence of temperature and storage time. Clin Chem 1999; 45: 430 -432.
29. Aakre KM, Thue G, Subramaniam-Haavik S, et al. Postanalytical external quality assessment of urine albumin in primary health care: an international survey. Clin Chem 2008; 54: 1630 -1636.
30. Chiang SC, Lee JK, Chen CH, et al. Justifying the high prevalence of microalbuminuria for type 2 diabetic patients in Taiwan with conditional probability approach -a DEMAND II study. J Chin Med Assoc 2011; 74: 3 -10.
31. Lu B, Wen J, Song XY, et al. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 2007; 75: 184 -192.
32. James GD, Sealey JE, Alderman M, et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens 1988; 1: 124 -131.
33. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med Overseas Ed 2003; 348: 383 -393.
34. Asselbergs FW, Diercks GF, Hillege HL, et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004; 110: 2809 -2816.
35. Atthobari J, Asselbergs FW, Boersma C, et al. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther 2006;28:432 -444.
36. Ninomiya T, Kiyohara Y, Kubo M, et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006; 48: 383 -391.
37. Bonnet F, Marre M, Halimi JM, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 2006; 24: 1157 -1163.
38. Mangione F, Esposito C, Dal Canton A. Cost-effectiveness of screening for and treating albuminuria in individuals without diabetes or hypertension: are we moving beyond the evidence. Am J Kidney Dis 2010; 56: 801; author reply 801 -802